“Not treating patients with osteoporosis drugs after a fracture would be like discharging a patient after a myocardial infarction without drugs to prevent a subsequent infarction,” researchers write in JAMA Internal Medicine.
This slideshow sums up the current literature on the practice of continuing or discontinuing therapies when rheumatoid arthritis is in remission or stable low disease activity.
Patient compliance is one of the most frustrating areas of medicine. Dr. Steven Feldman of Wake Forest University School of Medicine in North Carolina, offers some tried and true methods.
Aggressive treatment early in rheumatoid arthritis is the accepted practice today. In this slideshow, Dr. Litvin reminds us of patients diagnosed in the pre-biologics era.
In this slideshow, we summarize each of the 11 new gout treatment guidelines issued by EULAR in July.
Today’s therapeutic practices in rheumatology could one day go the way of the rotary telephone due to advances in imaging, proteomics and other areas.
Sometimes it’s not enough to ask "How are you feeling?” In this slideshow, we list eight communication pitfalls physicians should avoid.
Some new and old concepts to consider when evaluating patients with severe psoriatic arthritis (PsA) for cardiovascular diseases.
Physicians should understand the key features of MACRA and changes that lie ahead, say Duke University healthcare policy experts writing in JAMA
There are many misconceptions about adding fusion to decompression surgery for lumbar spinal stenosis. In this slideshow, we breakdown the new data on this surgery combo.